• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.老年急性髓系白血病微移植专家共识——国际微移植兴趣小组报告
Heliyon. 2023 Mar 31;9(4):e14924. doi: 10.1016/j.heliyon.2023.e14924. eCollection 2023 Apr.
2
Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia.基于 Hyper-CVAD 的干细胞微移植作为急性淋巴细胞白血病缓解后治疗。
Stem Cells Transl Med. 2022 Nov 18;11(11):1113-1122. doi: 10.1093/stcltm/szac066.
3
Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study.70岁以上急性髓系白血病患者的造血干细胞微移植:一项多中心研究。
Am J Cancer Res. 2023 Apr 15;13(4):1509-1521. eCollection 2023.
4
HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group.HLA 错配微移植治疗新诊断的老年急性髓系白血病患者:来自微移植兴趣小组的结果。
JAMA Oncol. 2018 Jan 1;4(1):54-62. doi: 10.1001/jamaoncol.2017.2656.
5
[Clinical Efficacy and Survival Analysis of Adult Patients with Acute Myeloid Leukemia after Microtransplantation].[微小移植后成年急性髓系白血病患者的临床疗效及生存分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022 Oct;30(5):1361-1368. doi: 10.19746/j.cnki.issn.1009-2137.2022.05.010.
6
MICROtransplant to refractory acute myeloid leukemia in Egyptian population.微移植治疗埃及人群难治性急性髓系白血病。
Curr Opin Hematol. 2019 Nov;26(6):379-385. doi: 10.1097/MOH.0000000000000547.
7
Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: A tale of misnomers, controversy and the unresolved.髓系肉瘤、绿色瘤或髓外急性髓系白血病肿瘤:一个关于误称、争议与未解之谜的故事。
Blood Rev. 2021 May;47:100773. doi: 10.1016/j.blre.2020.100773. Epub 2020 Oct 30.
8
Comparable Outcomes After Alternative and Matched Sibling Donor Hematopoietic Stem Cell Transplantation and the Role of Molecular Measurable Residual Disease for Acute Myeloid Leukemia in Elderly Patients.老年急性髓系白血病患者采用不同供者来源造血干细胞移植及分子可测残留病对其预后的影响
Transplant Cell Ther. 2021 Sep;27(9):774.e1-774.e12. doi: 10.1016/j.jtct.2021.05.024. Epub 2021 May 31.
9
Comparative study of micro-transplantation from HLA fully mismatched unrelated and partly matched related donors in acute myeloid leukemia.HLA 完全不合的无关供者与部分相合的亲缘供者间微移植治疗急性髓系白血病的比较研究。
Am J Hematol. 2020 Jun;95(6):630-636. doi: 10.1002/ajh.25780. Epub 2020 Apr 3.
10
A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.人类白细胞抗原不匹配细胞疗法(干细胞微移植)治疗高危骨髓增生异常综合征或转化型急性髓系白血病的研究
Stem Cells Transl Med. 2016 Apr;5(4):524-9. doi: 10.5966/sctm.2015-0196. Epub 2016 Feb 2.

引用本文的文献

1
Clonal Evolution of Myeloid Malignancies Treated With Microtransplantation: A Single-Centre Experience.微移植治疗的髓系恶性肿瘤的克隆进化:单中心经验
J Cell Mol Med. 2025 Mar;29(6):e70520. doi: 10.1111/jcmm.70520.
2
Hematopoietic stem cell microtransplantation: current situation and challenges.造血干细胞微移植:现状与挑战
Ther Adv Hematol. 2025 Jan 2;16:20406207241310332. doi: 10.1177/20406207241310332. eCollection 2025.
3
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.“拉撒路反应”:胎儿-母体微嵌合体发挥作用时,双胎妊娠后难治性原发性纵隔B细胞淋巴瘤出现自发缓解
Diagnostics (Basel). 2024 Sep 20;14(18):2084. doi: 10.3390/diagnostics14182084.
4
Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase.沉默调节蛋白5通过对甘氨酸脱羧酶进行琥珀酰化修饰来调节急性髓性白血病细胞的活力和凋亡。
Open Life Sci. 2024 Mar 16;19(1):20220832. doi: 10.1515/biol-2022-0832. eCollection 2024.

本文引用的文献

1
Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia.基于 Hyper-CVAD 的干细胞微移植作为急性淋巴细胞白血病缓解后治疗。
Stem Cells Transl Med. 2022 Nov 18;11(11):1113-1122. doi: 10.1093/stcltm/szac066.
2
The clinical application of SNP-based next-generation sequencing (SNP-NGS) for evaluation of chimerism and microchimerism after HLA-mismatched stem cell microtransplantation.基于 SNP 的新一代测序 (SNP-NGS) 在 HLA 错配造血干细胞微移植后嵌合体和微嵌合体评估中的临床应用。
Int J Hematol. 2022 Nov;116(5):723-730. doi: 10.1007/s12185-022-03415-8. Epub 2022 Jul 8.
3
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.成人 AML 的诊断与治疗:ELN 专家组代表发布的 2022 年国际专家建议
Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867.
4
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.国际髓系肿瘤和急性白血病分类:整合形态学、临床和基因组数据。
Blood. 2022 Sep 15;140(11):1200-1228. doi: 10.1182/blood.2022015850.
5
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells.基于动员的基因编辑人造血干细胞无化疗植入。
Cell. 2022 Jun 23;185(13):2248-2264.e21. doi: 10.1016/j.cell.2022.04.039. Epub 2022 May 25.
6
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status.口服阿扎胞苷可延长 AML 缓解患者的生存时间,而与可测量残留病状态无关。
Blood. 2022 Apr 7;139(14):2145-2155. doi: 10.1182/blood.2021013404.
7
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia.异基因造血细胞移植治疗老年急性髓系白血病的疗效。
Best Pract Res Clin Haematol. 2021 Dec;34(4):101320. doi: 10.1016/j.beha.2021.101320. Epub 2021 Oct 22.
8
Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病检测
Cancers (Basel). 2021 Oct 29;13(21):5431. doi: 10.3390/cancers13215431.
9
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.2021 年急性髓系白血病微小残留病更新:来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2021 Dec 30;138(26):2753-2767. doi: 10.1182/blood.2021013626.
10
Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial.60 至 70 岁老年患者接受急性髓细胞性白血病低强度移植的结果:NCRI 急性髓性白血病 16 号试验的结果。
Haematologica. 2022 Jul 1;107(7):1518-1527. doi: 10.3324/haematol.2021.279010.

老年急性髓系白血病微移植专家共识——国际微移植兴趣小组报告

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

作者信息

Ai Huisheng, Chao Nelson J, Rizzieri David A, Huang Xiaojun, Spitzer Thomas R, Wang Jianxiang, Guo Mei, Keating Armand, Krakow Elizabeth F, Blaise Didier, Ma Jun, Wu Depei, Reagan John, Gergis Usama, Duarte Rafael F, Chaudhary Preet M, Hu Kaixun, Yu Changlin, Sun Qiyun, Fuchs Ephraim, Cai Bo, Huang Yajing, Qiao Jianhui, Gottlieb David, Schultz Kirk R, Liu Mingyao, Chen Xiequn, Chen Wenming, Wang Jianmin, Zhang Xiaohui, Li Jianyong, Huang He, Sun Zimin, Li Fei, Yang Linhua, Zhang Liansheng, Li Lijuan, Liu Kaiyan, Jin Jie, Liu Qifa, Liu Daihong, Gao Chunji, Fan Chuanbo, Wei Li, Zhang Xi, Hu Liangding, Zhang Weijing, Tian Yuyang, Han Weidong, Zhu Jun, Xiao Zhijian, Zhou Daobin, Zhang Bolong, Jia Yongqian, Zhang Yongqing, Wu Xiaoxiong, Shen Xuliang, Lu Xuzhang, Zhan Xinrong, Sun Xiuli, Xiao Yi, Wang Jingbo, Shi Xiaodong, Zheng Bo, Chen Jieping, Ding Banghe, Wang Zhao, Zhou Fan, Zhang Mei, Zhang Yizhuo, Sun Jie, Xia Bing, Chen Baoan, Ma Liangming

机构信息

Chinese PLA General Hospital, China.

Duke University, USA.

出版信息

Heliyon. 2023 Mar 31;9(4):e14924. doi: 10.1016/j.heliyon.2023.e14924. eCollection 2023 Apr.

DOI:10.1016/j.heliyon.2023.e14924
PMID:37089296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10119710/
Abstract

Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients, based on analysis of the literature on MST, especially MST with EAML from January 1st, 2011 to November 30th, 2022, the International Microtransplant Interest Group provides recommendations and considerations for MST in the treatment of EAML. Four major issues related to MST for treating EAML were addressed: therapeutic principle of MST (1), candidates for MST (2), induction chemotherapy regimens (3), and post-remission therapy based on MST (4). Others included donor screening, infusion of donor cells, laboratory examinations, and complications of treatment.

摘要

近期研究表明,微移植(MST)可改善老年急性髓系白血病(EAML)患者的预后。为进一步规范MST治疗并改善EAML患者的预后,基于对MST文献的分析,特别是2011年1月1日至2022年11月30日期间EAML的MST文献,国际微移植兴趣小组提供了关于MST治疗EAML的建议和注意事项。讨论了与MST治疗EAML相关的四个主要问题:MST的治疗原则(1)、MST的候选者(2)、诱导化疗方案(3)以及基于MST的缓解后治疗(4)。其他包括供体筛查、供体细胞输注、实验室检查和治疗并发症。